Amendment of regulation 31 (certification of manufacturer's licence)U.K.
This
adran has no associated
Memorandwm Esboniadol
24.—(1) Regulation 31 is amended as follows.
(2) In paragraph (1)(c), for “an EEA State” substitute “ the United Kingdom ”.
[F1(3) In paragraphs (3)(b), (5)(a) and (5)(b) for “marketing authorisation” substitute “UK marketing authorisation, EU marketing authorisation, Article 126a authorisation”.]
Textual Amendments
F1Reg. 24(3) substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 16
Commencement Information
I1Reg. 24 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1